HAE EPS Estimates
Haemonetics Corporation
$118.28
-$3.01(-2.48%)
77
Overall
80
Value
83
Tech
68
Quality
Market Cap
$5.52B
Volume
467.01K
52W Range
$48.55 - $121.19
Target Price
$124.36
HAE EPS estimates: the consensus estimate for Haemonetics Corporation's current fiscal year is $5.29 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
HAE EPS Estimates
- EPS estimate, current quarter
- $1.30
- EPS estimate, next quarter
- $1.36
- EPS estimate, current year
- $5.29
- EPS estimate, next year
- $5.73
- EPS growth, 3-year
- -3.18%
| Fiscal year | EPS |
|---|---|
| 2026 | $2.06 |
| 2025 | $3.33 |
| 2024 | $2.32 |
| 2023 | $2.27 |
| 2022 | $0.85 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HAE | $118.28 | -2.5% | 467.01K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |